Single-ventricle palliation in children with atrioventricular septal defect and transposition of the great arteries: 45 years of experience.


Journal

Cardiology in the young
ISSN: 1467-1107
Titre abrégé: Cardiol Young
Pays: England
ID NLM: 9200019

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 1 7 2020
medline: 22 6 2021
entrez: 30 6 2020
Statut: ppublish

Résumé

The association of atrioventricular septal defect and transposition of the great arteries is very rare. As a rule, these patients have unbalanced ventricles. However, there have been no studies describing the results of single-ventricle palliation in these children. All children who underwent surgery with a diagnosis of atrioventricular septal defect and transposition of the great arteries were included in the study. Data were obtained from medical records. A total of 38 patients with atrioventricular septal defect and transposition of the great arteries underwent single-ventricle palliation at the study institution between 1971 and 2016. The mean follow-up was 12.4 years (median: 14.6 years, range 2-43.3 years). Most children had unbalanced atrioventricular septal defect (94.7%, 36/38). Survival was 67.6% (95% confidence interval [CI]: 50.0-80.2%) at 10 years and 57.8% (95% CI: 38.0-73.4%) at 20 years. By 10 years, 58.6% (95% CI: 40.8-72.7%) had progressed to Fontan completion, while 32.5% (95% CI: 18.2-47.6%) had died. In patients achieving Fontan completion, 20-year event-free survival was 73.3% (95% CI: 34.8-91.3%), while 5.0% (95% CI: 0.4-20.5%) had undergone cardiac transplantation and 21.7% (95% CI: 3.2-50.8%) had undergone takedown of the Fontan circulation. Freedom from atrioventricular valve surgery was 57.0% (95% CI: 37.2-72.7%) at 10 and 20 years. The association of atrioventricular septal defect and transposition of the great arteries is very rare, and most of these children have unbalanced ventricles. Single-ventricle palliation results in 25-year overall survival of 50%. However, in patients, who had Fontan completion, survival was 75% at 25 years after Fontan operation.

Sections du résumé

BACKGROUND BACKGROUND
The association of atrioventricular septal defect and transposition of the great arteries is very rare. As a rule, these patients have unbalanced ventricles. However, there have been no studies describing the results of single-ventricle palliation in these children.
METHODS METHODS
All children who underwent surgery with a diagnosis of atrioventricular septal defect and transposition of the great arteries were included in the study. Data were obtained from medical records.
RESULTS RESULTS
A total of 38 patients with atrioventricular septal defect and transposition of the great arteries underwent single-ventricle palliation at the study institution between 1971 and 2016. The mean follow-up was 12.4 years (median: 14.6 years, range 2-43.3 years). Most children had unbalanced atrioventricular septal defect (94.7%, 36/38). Survival was 67.6% (95% confidence interval [CI]: 50.0-80.2%) at 10 years and 57.8% (95% CI: 38.0-73.4%) at 20 years. By 10 years, 58.6% (95% CI: 40.8-72.7%) had progressed to Fontan completion, while 32.5% (95% CI: 18.2-47.6%) had died. In patients achieving Fontan completion, 20-year event-free survival was 73.3% (95% CI: 34.8-91.3%), while 5.0% (95% CI: 0.4-20.5%) had undergone cardiac transplantation and 21.7% (95% CI: 3.2-50.8%) had undergone takedown of the Fontan circulation. Freedom from atrioventricular valve surgery was 57.0% (95% CI: 37.2-72.7%) at 10 and 20 years.
CONCLUSIONS CONCLUSIONS
The association of atrioventricular septal defect and transposition of the great arteries is very rare, and most of these children have unbalanced ventricles. Single-ventricle palliation results in 25-year overall survival of 50%. However, in patients, who had Fontan completion, survival was 75% at 25 years after Fontan operation.

Identifiants

pubmed: 32594938
pii: S1047951120001791
doi: 10.1017/S1047951120001791
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1165-1170

Auteurs

Edward Buratto (E)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Tyson A Fricke (TA)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Xin Tao Ye (XT)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Johann Brink (J)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Christian P Brizard (CP)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Yves d'Udekem (Y)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Igor E Konstantinov (IE)

Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.
Melbourne Children's Centre for Cardiovascular Genomics and Regenerative Medicine, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH